LORRI DARROW: Open Payments
NPI 1679579593 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$28,109 in 147 payments from 20 companies in 2025. Trend: 2023 $1,813 · 2024 $15,558 · 2025 $28,109
Speaker / faculty: $23,768Food & beverage: $3,075Travel & lodging: $1,266
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 43 | $25,891 |
| Teva Pharmaceuticals USA, Inc. | 22 | $430 |
| Neurocrine BioSciences, Inc. | 11 | $333 |
| Vanda Pharmaceuticals Inc. | 10 | $291 |
| E.R. Squibb & Sons, L.L.C. | 14 | $190 |
| Axsome Therapeutics, Inc. | 5 | $180 |
| ABBVIE INC. | 17 | $169 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $136 |
| Janssen Pharmaceuticals, Inc | 1 | $97 |
| Alkermes, Inc. | 5 | $75 |
Products named: REXULTI, ABILIFY MAINTENA, INGREZZA, UZEDY, AUSTEDO XR, COBENFY, HETLIOZ, Auvelity.
Industry payments across MO — which companies pay providers there.
